The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 18, 2017
Filed:
Mar. 25, 2016
Applicant:
Panoptica, Inc., Bernardsville, NJ (US);
Inventors:
David P. Bingaman, Weatherford, TX (US);
Paul G. Chaney, Mount Arlington, NJ (US);
Martin B. Wax, Far Hills, NJ (US);
Assignee:
PanOptica, Inc., Bernardsville, NJ (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/427 (2006.01); A61K 31/425 (2006.01); A61K 31/122 (2006.01); A61K 9/00 (2006.01); A61K 31/00 (2006.01); A61K 9/08 (2006.01);
U.S. Cl.
CPC ...
A61K 31/425 (2013.01); A61K 9/0048 (2013.01); A61K 9/08 (2013.01); A61K 31/00 (2013.01); A61K 31/122 (2013.01); A61K 31/427 (2013.01);
Abstract
The present application relates to topical formulations comprising Compound-I or its free base, and a second active agent selected from nicotinic acid, nicotinamide, and vitamin K, and a combination thereof, for treating ocular neovascularization. The present application also relates to pharmaceutical compositions comprising particles of Compound-I or its free base, and suspension formulations comprising the particle compositions of Compound-I or its free base.